Together for better health

APCER Life Sciences is committed to improving health in partnership with its clients. We bring together safety, medical, regulatory, and technology resources to ensure that patients receive the safest, most effective therapies possible.


To achieve this mission, we’ve built a strong foundation. Our global infrastructure of scientific and medical experts, supported by integrated processes and regulatory-compliant technology systems, has proven to be responsive and scalable through exponential growth since our founding in 2007.


Leadership Team

APCER Life Sciences is led by an impressive group of executives with hands-on expertise in safety, medical and regulatory affairs, technology, and project governance. All have experience in guiding global organizations to function together as a unified team.

Meet the Team

We are global

It’s more than just a word at APCER Life Sciences. Global operations and relationships are the foundation of our business.

We are experts

APCER has deep industry knowledge and hands-on experience. Our clients value our safety, medical, regulatory, and technology expertise.

We find solutions

APCER takes ownership of the challenges you face. No matter how impossible a project may seem, we find solutions and meet your deadlines.

Together to build trust

What makes APCER Life Sciences different is the way we work together with our clients. We understand that trust is earned one project at a time, and we’ll start with a project as small as a single aggregate safety report to demonstrate the quality of our work. On the other hand, we stand ready and able to deliver a complete outsourced solution, across multiple continents, under the tightest of timeframes.


This flexibility and personalized service is why in a 2015 survey, APCER Life Sciences earned a perfect Net Promoter Score of 100. Every client surveyed said that they would highly recommend APCER as a service provider and viewed APCER favorably compared to large CROs and other specialty firms.



APCER Life Sciences is part of the APC Group, a global provider of active pharmaceutical ingredients (APIs) with an unblemished reputation for quality and support around the world.


APC was founded in 1987 in Hong Kong by APCER’s Chairman, Ravi Menon. The company grew rapidly by developing markets in India, China, and South East Asia for APIs and finished formulations produced by Western pharmaceutical manufacturers. Offices were added in Mumbai and Shanghai to satisfy the needs of both sellers and buyers.


As Asian manufacturers increased the quality of their products, APC Group was well positioned to provide APIs and finished formulations from India and China to the West and opened additional offices in Vietnam and Kazakhstan. APC also opened an office in Boston, MA, US, to provide regulatory, product selection, and consulting services to help its customers bridge the gap between China/India and the United States.


To respond to the increase in regulatory requirements around drug safety, APC expanded its services business with the formation of APCER Pharma Europe in 2007, headed by Dr. Vineet Kacker. The success of the business model and continued growth led to the establishment of APCER Pharma Solutions in the US. Today, these companies offer safety, medical, regulatory, and technology services around the world under the brand APCER Life Sciences.


APCER’s speed, responsiveness and flexibility to meet our safety needs is something we have always valued. APCER has helped harmonize our global pharmacovigilance operations and made us compliant with ever changing regulations.

– Medical Director, US-based specialty pharmaceutical company

We are grateful to APCER’s whole hearted efforts in delivering submission ready documents & IB’s that lead to spectacular results. Our relationship with APCER has helped us redefine our Safety and medical information setup.

– Global PV Head, US-based pharmaceutical company

We appreciate APCER for its efficiency in responding to matters that they get even at the eleventh hour. Working with APCER has made compliance a lot easier.

– AVP, Pharmacovigilance, US-based pharmaceutical company

APCER’s invaluable support with Clinical trial disclosure deadlines helped us in timely submissions of periodic reports.

– Head, Clinical Trial Transparency, Top 10 pharmaceutical company with operations in the EU and US

We are thankful to team APCER for bringing in strong practices & helping inspection readiness in our pharmacovigilance framework which led to successful FDA audits.

– Senior Director, US-based pharmaceutical company

The audit was carried out professionally and objectively. The scope of the audit was relevant and appropriate, and time efficient. The discussions during the audit were constructive and recommendations where helpful and appropriate. The team members involved in the audit had a positive experience and were made to feel at ease by the auditors.

– QPPV and Pharmacovigilance Head